These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 33737565)

  • 1. The TOMM40 '523' polymorphism in disease risk and age of symptom onset in two independent cohorts of Parkinson's disease.
    Bakeberg MC; Hoes ME; Gorecki AM; Theunissen F; Pfaff AL; Kenna JE; Plunkett K; Kõks S; Akkari PA; Mastaglia FL; Anderton RS
    Sci Rep; 2021 Mar; 11(1):6363. PubMed ID: 33737565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's disease susceptibility genes APOE and TOMM40, and brain white matter integrity in the Lothian Birth Cohort 1936.
    Lyall DM; Harris SE; Bastin ME; Muñoz Maniega S; Murray C; Lutz MW; Saunders AM; Roses AD; Valdés Hernández Mdel C; Royle NA; Starr JM; Porteous DJ; Wardlaw JM; Deary IJ
    Neurobiol Aging; 2014 Jun; 35(6):1513.e25-33. PubMed ID: 24508314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cis-regulatory effect of an Alzheimer's disease-associated poly-T locus on expression of TOMM40 and apolipoprotein E genes.
    Linnertz C; Anderson L; Gottschalk W; Crenshaw D; Lutz MW; Allen J; Saith S; Mihovilovic M; Burke JR; Welsh-Bohmer KA; Roses AD; Chiba-Falek O
    Alzheimers Dement; 2014 Sep; 10(5):541-51. PubMed ID: 24439168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease susceptibility genes APOE and TOMM40, and hippocampal volumes in the Lothian birth cohort 1936.
    Lyall DM; Royle NA; Harris SE; Bastin ME; Maniega SM; Murray C; Lutz MW; Saunders AM; Roses AD; del Valdés Hernández MC; Starr JM; Porteous DJ; Wardlaw JM; Deary IJ
    PLoS One; 2013; 8(11):e80513. PubMed ID: 24260406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TOMM40 and APOE common genetic variants are not Parkinson's disease risk factors.
    Peplonska B; Safranow K; Gaweda-Walerych K; Maruszak A; Czyzewski K; Rudzinska M; Barcikowska M; Zekanowski C
    Neurobiol Aging; 2013 Aug; 34(8):2078.e1-2. PubMed ID: 23522842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphism in the TOMM40 gene modifies the risk of developing sporadic inclusion body myositis and the age of onset of symptoms.
    Mastaglia FL; Rojana-udomsart A; James I; Needham M; Day TJ; Kiers L; Corbett JA; Saunders AM; Lutz MW; Roses AD;
    Neuromuscul Disord; 2013 Dec; 23(12):969-74. PubMed ID: 24103330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A TOMM40/APOE allele encoding APOE-E3 predicts high likelihood of late-onset Alzheimer's disease in autopsy cases.
    Soyal SM; Kwik M; Kalev O; Lenz S; Zara G; Strasser P; Patsch W; Weis S
    Mol Genet Genomic Med; 2020 Aug; 8(8):e1317. PubMed ID: 32472747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive search for Alzheimer disease susceptibility loci in the APOE region.
    Jun G; Vardarajan BN; Buros J; Yu CE; Hawk MV; Dombroski BA; Crane PK; Larson EB; ; Mayeux R; Haines JL; Lunetta KL; Pericak-Vance MA; Schellenberg GD; Farrer LA
    Arch Neurol; 2012 Oct; 69(10):1270-9. PubMed ID: 22869155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of an intronic polymorphism in TOMM40 and APOE genotypes in sporadic inclusion body myositis.
    Gang Q; Bettencourt C; Machado PM; Fox Z; Brady S; Healy E; Parton M; Holton JL; Hilton-Jones D; Shieh PB; Zanoteli E; De Paepe B; De Bleecker J; Shaibani A; Ripolone M; Violano R; Moggio M; Barohn RJ; Dimachkie MM; Mora M; Mantegazza R; Zanotti S; Hanna MG; Houlden H;
    Neurobiol Aging; 2015 Apr; 36(4):1766.e1-1766.e3. PubMed ID: 25670332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of TOMM40 polymorphisms with late-onset Alzheimer's disease in a Northern Han Chinese population.
    Ma XY; Yu JT; Wang W; Wang HF; Liu QY; Zhang W; Tan L
    Neuromolecular Med; 2013 Jun; 15(2):279-87. PubMed ID: 23288655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal modeling of cognitive aging and the TOMM40 effect.
    Caselli RJ; Dueck AC; Huentelman MJ; Lutz MW; Saunders AM; Reiman EM; Roses AD
    Alzheimers Dement; 2012 Nov; 8(6):490-5. PubMed ID: 23102119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TOMM40 and APOE variants synergistically increase the risk of Alzheimer's disease in a Chinese population.
    Zhu Z; Yang Y; Xiao Z; Zhao Q; Wu W; Liang X; Luo J; Cao Y; Shao M; Guo Q; Ding D
    Aging Clin Exp Res; 2021 Jun; 33(6):1667-1675. PubMed ID: 32725468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TOMM40 polymorphisms in Italian Alzheimer's disease and frontotemporal dementia patients.
    Bagnoli S; Piaceri I; Tedde A; Bessi V; Bracco L; Sorbi S; Nacmias B
    Neurol Sci; 2013 Jun; 34(6):995-8. PubMed ID: 23546992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TOMM40 intron 6 poly-T length, age at onset, and neuropathology of AD in individuals with APOE ε3/ε3.
    Li G; Bekris LM; Leong L; Steinbart EJ; Shofer JB; Crane PK; Larson EB; Peskind ER; Bird TD; Yu CE
    Alzheimers Dement; 2013 Sep; 9(5):554-61. PubMed ID: 23183136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between TOMM40 Poly-T Repeat Variants and Dementia in Cases with Parkinsonism.
    Lindqvist D; Prokopenko I; Londos E; Middleton L; Hansson O
    J Parkinsons Dis; 2016; 6(1):99-108. PubMed ID: 26756745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of the TOMM40 poly-T alleles on Alzheimer's disease phenotypes.
    Chiba-Falek O; Gottschalk WK; Lutz MW
    Alzheimers Dement; 2018 May; 14(5):692-698. PubMed ID: 29524426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation of TOMM40-APOE-APOC2 in Alzheimer's disease.
    Shao Y; Shaw M; Todd K; Khrestian M; D'Aleo G; Barnard PJ; Zahratka J; Pillai J; Yu CE; Keene CD; Leverenz JB; Bekris LM
    J Hum Genet; 2018 Apr; 63(4):459-471. PubMed ID: 29371683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of TOMM40 poly-T length on gray matter volume and cognition in middle-aged persons with APOE ε3/ε3 genotype.
    Johnson SC; La Rue A; Hermann BP; Xu G; Koscik RL; Jonaitis EM; Bendlin BB; Hogan KJ; Roses AD; Saunders AM; Lutz MW; Asthana S; Green RC; Sager MA
    Alzheimers Dement; 2011 Jul; 7(4):456-65. PubMed ID: 21784354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A candidate gene study of risk for dementia in older, postmenopausal women: Results from the Women's Health Initiative Memory Study.
    Driscoll I; Snively BM; Espeland MA; Shumaker SA; Rapp SR; Goveas JS; Casanova RL; Wactawski-Wende J; Manson JE; Rossom R; Brooks J; Hernandez DG; Singleton AB; Resnick SM
    Int J Geriatr Psychiatry; 2019 May; 34(5):692-699. PubMed ID: 30706571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TOMM40 '523' poly-T repeat length is a determinant of longitudinal cognitive decline in Parkinson's disease.
    Bakeberg MC; Gorecki AM; Pfaff AL; Hoes ME; Kõks S; Akkari PA; Mastaglia FL; Anderton RS
    NPJ Parkinsons Dis; 2021 Jul; 7(1):56. PubMed ID: 34234128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.